• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心血管疾病一级预防的风险评估:适当风险预测模型选择的考虑因素。

Risk estimation for the primary prevention of cardiovascular disease: considerations for appropriate risk prediction model selection.

机构信息

British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK; Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK.

Population Health Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia; School of Public Health, University of Queensland, Brisbane, QLD, Australia; Epidemiology and Population Health, The Australian National University, Canberra, ACT, Australia.

出版信息

Lancet Glob Health. 2024 Aug;12(8):e1343-e1358. doi: 10.1016/S2214-109X(24)00210-9.

DOI:10.1016/S2214-109X(24)00210-9
PMID:39030064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11283887/
Abstract

Cardiovascular diseases remain the number one cause of death globally. Cardiovascular disease risk scores are an integral tool in primary prevention, being used to identify individuals at the highest risk and guide the assignment of preventive interventions. Available risk scores differ substantially in terms of the population sample data sources used for their derivation and, consequently, in the absolute risks they assign to individuals. Differences in cardiovascular disease epidemiology between the populations contributing to the development of risk scores, and the target populations in which they are applied, can result in overestimation or underestimation of cardiovascular disease risks for individuals, and poorly informed clinical decisions. Given the wide plethora of cardiovascular disease risk scores available, identification of an appropriate risk score for a target population can be challenging. This Review provides an up-to-date overview of guideline-recommended cardiovascular disease risk scores from global, regional, and national contexts, evaluates their comparative characteristics and qualities, and provides guidance on selection of an appropriate risk score.

摘要

心血管疾病仍然是全球头号死因。心血管疾病风险评分是初级预防的重要工具,用于识别风险最高的个体,并指导预防干预措施的分配。现有的风险评分在用于推导的人群样本数据来源方面存在很大差异,因此,它们为个体分配的绝对风险也不同。导致风险评分发展的人群与应用风险评分的目标人群之间心血管疾病流行病学的差异,可能导致个体心血管疾病风险的高估或低估,以及临床决策信息不足。鉴于现有的心血管疾病风险评分种类繁多,为目标人群确定合适的风险评分可能具有挑战性。这篇综述提供了全球、区域和国家背景下指南推荐的心血管疾病风险评分的最新概述,评估了它们的比较特征和质量,并就选择合适的风险评分提供了指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e71/11283887/2dafd8a3c8e4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e71/11283887/2dafd8a3c8e4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e71/11283887/2dafd8a3c8e4/gr1.jpg

相似文献

1
Risk estimation for the primary prevention of cardiovascular disease: considerations for appropriate risk prediction model selection.心血管疾病一级预防的风险评估:适当风险预测模型选择的考虑因素。
Lancet Glob Health. 2024 Aug;12(8):e1343-e1358. doi: 10.1016/S2214-109X(24)00210-9.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Prediction models for the risk of cardiovascular disease in patients with type 2 diabetes: a systematic review.2 型糖尿病患者心血管疾病风险预测模型:系统综述。
Heart. 2012 Mar;98(5):360-9. doi: 10.1136/heartjnl-2011-300734. Epub 2011 Dec 18.
4
Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.阿司匹林用于心血管疾病和癌症一级预防的预防性使用:系统评价和综述概述。
Health Technol Assess. 2013 Sep;17(43):1-253. doi: 10.3310/hta17430.
5
Risk prediction tools in cardiovascular disease prevention: A report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP).心血管疾病预防中的风险预测工具:ESC 预防心血管疾病项目报告,该项目由欧洲预防心脏病学协会(EAPC)牵头,与急性心血管护理协会(ACCA)和心血管护理及相关专业协会(ACNAP)合作完成。
Eur Heart J Acute Cardiovasc Care. 2020 Aug;9(5):522-532. doi: 10.1177/2048872619858285. Epub 2019 Jun 25.
6
Overview of Risk-Estimation Tools for Primary Prevention of Cardiovascular Diseases in European Populations.欧洲人群心血管疾病一级预防风险评估工具概述
Cent Eur J Public Health. 2015 Jun;23(2):91-9. doi: 10.21101/cejph.a4004.
7
Overestimation and underestimation of cardiovascular risk in clinical practice: usefulness of risk estimation charts.临床实践中对心血管风险的高估与低估:风险评估图表的作用
Hellenic J Cardiol. 2007 Nov-Dec;48(6):341-5.
8
Assessing gaps in cholesterol treatment guidelines for primary prevention of cardiovascular disease based on available randomised clinical trial evidence: The Rotterdam Study.基于现有随机临床试验证据评估心血管疾病一级预防中胆固醇治疗指南的差距:鹿特丹研究。
Eur J Prev Cardiol. 2018 Mar;25(4):420-431. doi: 10.1177/2047487317743352. Epub 2017 Nov 24.
9
Risk scoring for the primary prevention of cardiovascular disease.心血管疾病一级预防的风险评分
Cochrane Database Syst Rev. 2017 Mar 14;3(3):CD006887. doi: 10.1002/14651858.CD006887.pub4.
10
Socioeconomic Deprivation: An Important, Largely Unrecognized Risk Factor in Primary Prevention of Cardiovascular Disease.社会经济剥夺:心血管疾病一级预防中一个重要但很大程度上被忽视的危险因素。
Circulation. 2022 Jul 19;146(3):240-248. doi: 10.1161/CIRCULATIONAHA.122.060042. Epub 2022 Jun 24.

引用本文的文献

1
Prevalence of high 10-year cardiovascular risk among the general population in Malaysia and the associated factors: a nationwide community-based study in 2023.马来西亚普通人群中10年心血管疾病高风险的患病率及其相关因素:2023年一项基于全国社区的研究
BMC Public Health. 2025 Aug 8;25(1):2706. doi: 10.1186/s12889-025-23748-3.
2
Korean Cardiovascular Health Status Assessed by Life's Essential 8 in Korean Adult Population: Based on Data From the Korean National Health and Nutrition Examination Survey 2014-2021.通过“生命八大要素”评估韩国成年人群的心血管健康状况:基于2014 - 2021年韩国国家健康与营养检查调查数据
Korean Circ J. 2025 Aug;55(8):736-752. doi: 10.4070/kcj.2024.0411. Epub 2025 Apr 30.
3

本文引用的文献

1
TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods.TRIPOD+AI 声明:报告使用回归或机器学习方法的临床预测模型的更新指南。
BMJ. 2024 Apr 16;385:e078378. doi: 10.1136/bmj-2023-078378.
2
Evaluation of clinical prediction models (part 2): how to undertake an external validation study.临床预测模型的评估(第 2 部分):如何进行外部验证研究。
BMJ. 2024 Jan 15;384:e074820. doi: 10.1136/bmj-2023-074820.
3
Evaluation of clinical prediction models (part 1): from development to external validation.
[Association of triglyceride-glucose index and cardiovascular disease in a community-based Chinese cohort].
[基于社区的中国队列中甘油三酯-葡萄糖指数与心血管疾病的关联]
Beijing Da Xue Xue Bao Yi Xue Ban. 2025 Jun 18;57(3):430-435. doi: 10.19723/j.issn.1671-167X.2025.03.004.
4
PRMT1 inhibition enhances the cardioprotective effect of adipose-derived mesenchymal stem cells against myocardial infarction through RUNX1.蛋白精氨酸甲基转移酶1(PRMT1)抑制通过RUNX1增强脂肪来源间充质干细胞对心肌梗死的心脏保护作用。
Stem Cell Res Ther. 2025 Jun 3;16(1):279. doi: 10.1186/s13287-025-04409-z.
5
Association between immune checkpoint inhibitors and cardiovascular risks: a nationwide self-controlled case series study.免疫检查点抑制剂与心血管风险之间的关联:一项全国性自我对照病例系列研究。
Am J Cancer Res. 2025 Apr 15;15(4):1820-1828. doi: 10.62347/ZUUA2691. eCollection 2025.
6
Cardiovascular Risk Assessment and Lipid-Lowering Therapy Recommendations in Primary Prevention.初级预防中的心血管风险评估及降脂治疗建议
J Clin Med. 2025 Mar 25;14(7):2220. doi: 10.3390/jcm14072220.
7
Troponin Testing for Cardiovascular Primary Prevention Decision Making?肌钙蛋白检测用于心血管疾病一级预防的决策制定?
J Am Coll Cardiol. 2025 Apr 15;85(14):1485-1487. doi: 10.1016/j.jacc.2025.02.026.
8
Harnessing Electronic Health Records and Artificial Intelligence for Enhanced Cardiovascular Risk Prediction: A Comprehensive Review.利用电子健康记录和人工智能增强心血管疾病风险预测:一项全面综述。
J Am Heart Assoc. 2025 Mar 18;14(6):e036946. doi: 10.1161/JAHA.124.036946. Epub 2025 Mar 13.
9
Deep Learning-Based Detection of Carotid Plaques Informs Cardiovascular Risk Prediction and Reveals Genetic Drivers of Atherosclerosis.基于深度学习的颈动脉斑块检测为心血管风险预测提供信息并揭示动脉粥样硬化的遗传驱动因素。
medRxiv. 2024 Oct 18:2024.10.17.24315675. doi: 10.1101/2024.10.17.24315675.
临床预测模型的评估(第 1 部分):从建立到外部验证。
BMJ. 2024 Jan 8;384:e074819. doi: 10.1136/bmj-2023-074819.
4
Clinical prediction models and the multiverse of madness.临床预测模型与疯狂的多元宇宙。
BMC Med. 2023 Dec 18;21(1):502. doi: 10.1186/s12916-023-03212-y.
5
Global Burden of Cardiovascular Diseases and Risks, 1990-2022.1990 - 2022年心血管疾病及其风险的全球负担
J Am Coll Cardiol. 2023 Dec 19;82(25):2350-2473. doi: 10.1016/j.jacc.2023.11.007.
6
Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association.纳入心血管-肾脏-代谢健康因素的全心血管疾病绝对风险评估新预测方程:美国心脏协会科学声明
Circulation. 2023 Dec 12;148(24):1982-2004. doi: 10.1161/CIR.0000000000001191. Epub 2023 Nov 10.
7
Development and Validation of the American Heart Association's PREVENT Equations.美国心脏协会 PREVENT 方程的制定与验证。
Circulation. 2024 Feb 6;149(6):430-449. doi: 10.1161/CIRCULATIONAHA.123.067626. Epub 2023 Nov 10.
8
Economic burden of cardiovascular diseases in the European Union: a population-based cost study.欧盟心血管疾病的经济负担:一项基于人群的成本研究。
Eur Heart J. 2023 Dec 1;44(45):4752-4767. doi: 10.1093/eurheartj/ehad583.
9
Evidence supporting the choice of a new cardiovascular risk equation for Australia.支持为澳大利亚选择新心血管风险方程的证据。
Med J Aust. 2023 Aug 21;219(4):173-186. doi: 10.5694/mja2.52052. Epub 2023 Jul 26.
10
Estimating individual lifetime risk of incident cardiovascular events in adults with Type 2 diabetes: an update and geographical calibration of the DIAbetes Lifetime perspective model (DIAL2).评估2型糖尿病成人发生心血管事件的个体终生风险:糖尿病终生视角模型(DIAL2)的更新与地理校准
Eur J Prev Cardiol. 2023 Jan 11;30(1):61-69. doi: 10.1093/eurjpc/zwac232.